PARKLAND HLTH CTR - BONNE TERRE — History
CCN 261315 | 3-year financial timeline | COVID resilience: 74/100
🛡️ Public data only — no PHI permitted on this instance.
$124M
Latest Revenue (FY2022)
+13.1%
Revenue CAGR (3yr)
3.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $97M | $120M | $124M | +3.8% | +13.1% |
| Operating Expenses | $99M | $111M | $120M | +8.9% | +10.3% |
| Operating Margin | -1.9% | 7.6% | 3.1% | -59.9% | +0.0% |
| Net Income | $-2M | $9M | $4M | -58.4% | +0.0% |
| Licensed Beds | 3 | 3 | 3 | +0.0% | +0.0% |
| Total Patient Days | 46 | 50 | 54 | +8.0% | +8.3% |
| Medicare Day % | 28% | 32% | 24% | -24.8% | -7.7% |
| Medicaid Day % | 11% | 2% | 20% | +918.5% | +36.9% |
COVID Impact & Recovery
Resilience Score: 74/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +27.9% ($97M → $124M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+13.1%
This Hospital
+7.6%
State Avg
Latest Margin
3.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $138M | 5.5% |
| FY2024 (proj) | $151M | 8.0% |
| FY2025 (proj) | $165M | 10.5% |